The Association of Opioid Misuse and Suicidality among People with Disabilities

References

• Ahmad, F. B., & Anderson, R. N. (2021). The leading causes of death in the US for 2020. JAMA, 325(18), 1829–1830. https://doi.org/10.1001/jama.2021.5469
   PubMed Web of Science ®Google Scholar
• Baiden, P., Graaf, G., Zaami, M., Acolatse, C. K., & Adeku, Y. (2019). Examining the association between prescription opioid misuse and suicidal behaviors among adolescent high school students in the United States. Journal of Psychiatric Research, 112, 44–51. https://doi.org/10.1016/j.jpsychires.2019.02.018
   PubMed Web of Science ®Google Scholar
• Baumgartner, J. C., & Radley, D. C. (2022). Overdose deaths surged in the first half of 2021, underscoring the need for action. To the Point, Commonwealth Fund. https://doi.org/10.26099/tmae-je82
   Google Scholar
• Bohnert, A. S., & Ilgen, M. A. (2019). Understanding links among opioid use, overdose, and suicide. The New England Journal of Medicine, 380(1), 71–79. https://doi.org/10.1056/NEJMra1802148
   PubMed Web of Science ®Google Scholar
• Carew, A. M., & Comiskey, C. (2018). Treatment for opioid use and outcomes in older adults: A systematic literature review. Drug and Alcohol Dependence, 182, 48–57. https://doi.org/10.1016/j.drugalcdep.2017.10.007
   PubMed Web of Science ®Google Scholar
• Center for Behavioral Health Statistics and Quality. (2020). 2019 National Survey on Drug Use and Health: Public use file codebook. Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Centers for Disease Control and Prevention. (2018). Leading causes of death by age group. https://www.cdc.gov/injury/images/lc-charts/leading_causes_of_death_by_age_group_2018_1100w850h.jpg
   Google Scholar
• Centers for Disease Control and Prevention. (2020). Web-based injury statistics query and reporting system. https://webappa.cdc.gov/sasweb/ncipc/leadcause.html
   Google Scholar
• Chan, K. T., Winston, P., Jennings, R., Trant, J. A., & Moller, M. (2019). Age differences in the association of non-medical prescription opioid use and suicidality. Journal of Opioid Management, 15(1), 5–10. https://doi.org/10.5055/jom.2019.0480
   PubMedGoogle Scholar
• Chan, K., Zhou, S.*, Marsack-Topolewski, C. (2020). Race differences in adolescent opioid misuse and suicidality. Child and Adolescent Social Work Journal. https://doi.org/10.1007/s10560-020-00721-0
   Google Scholar
• Clayton, H. B., Bohm, M. K., Lowry, R., Ashley, C., & Ethier, K. A. (2019). Prescription opioid misuse associated with risk behaviors among adolescents. American Journal of Preventive Medicine, 57(4), 533–539. https://doi.org/10.1016/j.amepre.2019.05.017
   PubMed Web of Science ®Google Scholar
• Cramer, J. D., Gunaseelan, V., Hu, H. M., Bicket, M. C., Waljee, J. F., & Brenner, M. J. (2021). Association of state opioid prescription duration limits with changes in opioid prescribing for Medicare beneficiaries. JAMA Internal Medicine, 181(12), 1656. https://doi.org/10.1001/jamainternmed.2021.4281
   PubMed Web of Science ®Google Scholar
• Cree, R. A., Okoro, C. A., Zack, M. M., & Carbone, E. (2020). Frequent mental distress among adults by disability status, disability type, and selected characteristics – United States 2018. Morbidity and Mortality Weekly Report (MMWR). https://www.cdc.gov/mmwr/volumes/69/wr/mm6936a2.htm
   Google Scholar
• Edlund, M. J., Booth, B. M., & Han, X. (2012). Who seeks care where? Utilization of mental health and substance use disorder treatment in two national samples of individuals with alcohol use disorders. Journal of Studies on Alcohol and Drugs, 73(4), 635–646. https://doi.org/10.15288/jsad.2012.73.635
   PubMed Web of Science ®Google Scholar
• Fischer, B., Lusted, A., Roerecke, M., Taylor, B., & Rehm, J. (2012). The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: A systematic review and meta-analysis. The Journal of Pain, 13(11), 1029–1044. https://doi.org/10.1016/j.jpain.2012.07.013
   PubMed Web of Science ®Google Scholar
• Folkman, S., Lazarus, R. S., Gruen, R. J., & DeLongis, A. (1986). Appraisal, coping, health status, and psychological symptoms. Journal of Personality and Social Psychology, 50(3), 571–579. https://doi.org/10.1037/0022-3514.50.3.571[PMC][3701593
   PubMed Web of Science ®Google Scholar
• Ford, J. A., Hinojosa, M. S., & Nicholson, H. L. (2018). Disability status and prescription drug misuse among US adults. Addictive Behaviors, 85, 64–69. https://doi.org/10.1016/j.addbeh.2018.05.019
   PubMed Web of Science ®Google Scholar
• Guo, L., Xu, Y., Deng, J., Huang, J., Huang, G., Gao, X., Wu, H., Pan, S., Zhang, W. H., & Lu, C. (2016). Association between nonmedical use of prescription drugs and suicidal behavior among adolescents. JAMA Pediatrics, 170(10), 971–978. https://doi.org/10.1001/jamapediatrics.2016.1802
   PubMed Web of Science ®Google Scholar
• Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. (2017). Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Annals of Internal Medicine, 167(5), 293–301. https://doi.org/10.7326/M17-0865
   PubMed Web of Science ®Google Scholar
• Han, B., Volkow, N. D., Compton, W. M., & McCance-Katz, E. F. (2020). Reported heroin use, use disorder, and injection among adults in the United States, 2002-2018. JAMA, 323(6), 568–571. https://doi.org/10.1001/jama.2019.20844
   PubMed Web of Science ®Google Scholar
• Hong, Y., Geraci, M., Turk, M. A., Love, B. L., & McDermott, S. W. (2019). Opioid prescription patterns for adults with longstanding disability and inflammatory conditions compared to other users, using a nationally representative sample. Archives of Physical Medicine and Rehabilitation, 100(1), 86–94.e2. https://doi.org/10.1016/j.apmr.2018.06.034
   PubMed Web of Science ®Google Scholar
• Husain-Krautter, S. (2019). Determining prevalence of substance use disorder in the geriatric population during consult services. American Journal of Geriatric Psychiatry, 27, S134–S135. https://doi.org/10.1016/j.jagp.2019.01.087
   Web of Science ®Google Scholar
• Ilgen, M. A., Bohnert, A. S., Ganoczy, D., Bair, M. J., McCarthy, J. F., & Blow, F. C. (2016). Opioid dose and risk of suicide. Pain, 157(5), 1079–1084. https://doi.org/10.1097/j.pain.0000000000000484
   PubMed Web of Science ®Google Scholar
• Kennedy, J., Burley, M., & Roll, J. (2018). The prevalence and treatment of opioid misuse among working-age adults with disabilities, 2016. Available online from https://static1.squarespace.com/static/5abe7e9b5ffd206d61d648ef/t/5af4765b1ae6cf375890b0d3/1525970524389/opioid_misuse_and_abuse.pdf
   Google Scholar
• Kessler, R. C., Andrews, G., Colpe, L. J., Hiripi, E., Mroczek, D. K., Normand, S. L. T., Walters, E. E., & Zaslavsky, A. M. (2002). Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychological Medicine, 32(6), 959–976. https://doi.org/10.1017/S0033291702006074
   PubMed Web of Science ®Google Scholar
• Khazem, L. R., Jahn, D. R., Cukrowicz, K. C., & Anestis, M. D. (2017). Health conditions, physical disabilities, perceived burdensomeness, and depressive symptoms influence suicidal ideation. Death Studies, 41(4), 220–225. https://doi.org/10.1080/07481187.2016.1251509
   PubMed Web of Science ®Google Scholar
• Lauer, E. A., Henly, M., & Brucker, D. L. (2019). Prescription opioid behaviors among adults with and without disabilities–United States, 2015–2016. Disability and Health Journal, 12(3), 519–522. https://doi.org/10.1016/j.dhjo.2018.12.001
   PubMed Web of Science ®Google Scholar
• Lazarus, R., & Folkman, S. (1984). Stress, appraisal, and coping. Springer Publishing Company.
   Google Scholar
• Lazarus, R. S. (1993). Coping theory and research: Past, present, and future. In Fifty years of the Research and Theory of RS Lazarus: An Analysis of Historical and Perennial Issues (1st ed., pp. 366–388). Psychology Press.
   Google Scholar
• Lewis, V. M., Williams, K., Koko, C., Woolmore, J., Jones, C., & Powell, T. (2017). Disability, depression and suicide ideation in people with multiple sclerosis. Journal of Affective Disorders, 208, 662–669. https://doi.org/10.1016/j.jad.2016.08.038
   PubMed Web of Science ®Google Scholar
• Mazereeuw, G., Sullivan, M. D., & Juurlink, D. N. (2018). Depression in chronic pain: Might opioids be responsible? Pain, 159(11), 2142–2145. https://doi.org/10.1097/j.pain.0000000000001305
   PubMed Web of Science ®Google Scholar
• McCabe, S. E., West, B. T., Veliz, P., McCabe, V. V., Stoddard, S. A., & Boyd, C. J. (2017). Trends in medical and nonmedical use of prescription opioids among US adolescents: 1976-2015. Pediatrics, 139(4), 1–9. https://doi.org/10.1542/peds.2016-2387
   Web of Science ®Google Scholar
• Meltzer, H., Brugha, T., Dennis, M. S., Hassiotis, A., Jenkins, R., McManus, S., Rai, D., & Bebbington, P. (2012). The influence of disability on suicidal behaviour. Alter, 6(1), 1–12. https://doi.org/10.1016/j.alter.2011.11.004
   Google Scholar
• Mojtabai, R., & Olfson, M. (2020). National trends in mental health care for US Adolescents. JAMA Psychiatry, 77(7), 703–714. https://doi.org/10.1001/jamapsychiatry.2020.0279
   PubMed Web of Science ®Google Scholar
• Mojtabai, R., Olfson, M., & Han, B. (2016). National trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics, 138(6), 1–1. https://doi.org/10.1542/peds.2016-1878
   Web of Science ®Google Scholar
• Morden, N. E., Munson, J. C., Colla, C. H., Skinner, J. S., Bynum, J. P., Zhou, W., & Meara, E. R. (2014). Prescription opioid use among disabled Medicare beneficiaries: Intensity, trends and regional variation. Medical Care, 52(9), 852–859. https://doi.org/10.1097/MLR.0000000000000183
   PubMed Web of Science ®Google Scholar
• National Institute on Disability, Independent Living, and Rehabilitation Research. (2018). Summary of response from a request for information: People with disabilities and opioid use disorder. Available online from https://acl.gov/sites/default/files/news%202018-05/20180502NIDILRROpioidRFIFindings.pdf
   Google Scholar
• Palmer, M., & Harley, D. (2012). Models and measurement in disability: An international review. Health Policy and Planning, 27(5), 357–364. https://doi.org/10.1093/heapol/czr047
   PubMed Web of Science ®Google Scholar
• Reif, S., Lauer, E. A., Adams, R. S., Brucker, D. L., Ritter, G. A., & Mitra, M. (2021). Examining differences in prescription opioid use behaviors among US adults with and without disabilities. Preventive Medicine, 153, 106754. https://doi.org/10.1016/j.ypmed.2021.106754
   PubMed Web of Science ®Google Scholar
• Russel, D., Turner, R. J., & Joiner, T. E. (2009). Physical disability and suicidal ideation: A community-based study of risk/protective factors for suicidal thoughts. Suicide & Life-Threatening Behavior, 39(4), 440–451.
   PubMed Web of Science ®Google Scholar
• Salas, J., Scherrer, J. F., Schneider, F. D., Sullivan, M. D., Bucholz, K. K., Burroughs, T., Copeland, L. A., Ahmedani, B. K., & Lustman, P. J. (2017). New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation. Pain, 158(2), 306–312. https://doi.org/10.1097/j.pain.0000000000000763
   PubMed Web of Science ®Google Scholar
• Scherrer, J. F., Salas, J., Copeland, L. A., Stock, E. M., Ahmedani, B. K., Sullivan, M. D., Burroughs, T., Schneider, F. D., Bucholz, K. K., & Lustman, P. J. (2016). Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations. Annals of Family Medicine, 14(1), 54–62. https://doi.org/10.1370/afm.1885
   PubMed Web of Science ®Google Scholar
• Sheridan, D. C., Laurie, A., Hendrickson, R. G., Fu, R., Kea, B., & Horowitz, B. Z. (2016). Association of overall opioid prescriptions on adolescent opioid abuse. The Journal of Emergency Medicine, 51(5), 485–490. https://doi.org/10.1016/j.jemermed.2016.06.049
   PubMed Web of Science ®Google Scholar
• Song, Z. (2017). Mortality quadrupled among opioid-driven hospitalizations, notably within lower-income and disabled white populations. Health Affairs (Project Hope), 36(12), 2054–2061. https://doi.org/10.1377/hlthaff.2017.0689
   PubMed Web of Science ®Google Scholar
• Streck, J. M., Parker, M. A., Bearnot, B., Kalagher, K., Sigmon, S. C., Goodwin, R. D., & Weinberger, A. H. (2022). National trends in suicide thoughts and behavior among US adults with opioid use disorder from 2015 to 2020. Substance Use & Misuse, 57(6), 876–885. https://doi.org/10.1080/10826084.2022.2046102
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2018). Reports and detailed tables from the 2017 National Survey on Drug Use and Health. https://www.samhsa.gov/data/nsduh/reports-detailed-tables-2017-NSDUH
   Google Scholar
• Sullivan, M. D. (2018). Depression effects on long-term prescription opioid use, abuse, and addiction. The Clinical Journal of Pain, 34(9), 878–884. https://doi.org/10.1097/AJP.0000000000000603
   PubMed Web of Science ®Google Scholar
• United Nations Statistics Division. (2017). Washington Group on Disability Statistics homepage. https://unstats.un.org/unsd/methods/citygroup/washington.htm
   Google Scholar
• Vadivelu, N., Kai, A. M., Kodumudi, V., Sramcik, J., & Kaye, A. D. (2018). The opioid crisis: A comprehensive overview. Current Pain and Headache Reports, 22(3), 16. https://doi.org/10.1007/s11916-018-0670-z[PMC][29476358
   PubMed Web of Science ®Google Scholar
• Verbrugge, L. M., & Jette, A. M. (1994). The disablement process. Social Science & Medicine, 38(1), 1–14. 10.1016/0277-9536(94)90294-1
   PubMed Web of Science ®Google Scholar
• Volkow, N. D., & McLellan, A. T. (2016). Opioid abuse in chronic pain—misconceptions and mitigation strategies. The New England Journal of Medicine, 374(13), 1253–1263. https://doi.org/10.1056/NEJMra1507771
   PubMed Web of Science ®Google Scholar
• Washington Group on Disability Statistics. (2017). WG conceptual framework. http://www.washingtongroup-disability.com/methodology-and-research/conceptual-framework/
   Google Scholar
• West, N. A., & Dart, R. C. (2016). Prescription opioid exposures and adverse outcomes among older adults. Pharmacoepidemiology and Drug Safety, 25(5), 539–544. https://doi.org/10.1002/pds.3934
   PubMed Web of Science ®Google Scholar
• Yarborough, B. H., Stumbo, S. P., Janoff, S. L., Yarborough, M. T., McCarty, D., Chilcoat, H. D., Coplan, P. M., & Green, C. A. (2016). Understanding opioid overdose characteristics involving prescription and illicit opioids: A mixed methods analysis. Drug and Alcohol Dependence, 167, 49–56. https://doi.org/10.1016/j.drugalcdep.2016.07.024
   PubMed Web of Science ®Google Scholar